Punawala said on Twitter that all countries would be allowed to export the vaccine.
Corona Vaccine in India: After harsh comments about each other, Ginger Punawala of Serum Institute of India (SII) and Krishna Ella of Bharat Biotech have expressed solidarity and hope that the company will supply and deliver Covid-19 vaccine together. I will. Read more – Corona vaccine in Bihar News: CM Nitish says – Who will be the first to get corona vaccine in Bihar
A joint statement said, “The two organizations pay tribute to the great work done by each other and leave behind the misunderstanding that occurred last week. We are fully aware of the importance of the vaccine. Together we will deliver the Covid-19 vaccine to another country.” Read more – Pfizer coroner vaccine update: Pfizer suspected, health worker killed in Portugal, side effects seen in Finland-Bulgaria
Earlier on Monday, Bharat raised questions about the quality of the test at the Biotech Serum Institute. “Protecting the lives and livelihoods of the people of India and the world is the most important task before them,” he said. Read more – Not only India, Pakistan is also conducting ‘Kovacin’ trial, the agency answers every question of the opposition
A day earlier, Adar Punawala, head of the Serum Institute of India, had said that India would not allow the export of the Oxford-Astrancar coronavirus vaccine for several months. But now, a day after his statement, the CEO of the company issued a clarification on Tuesday.
Punawala said on Twitter that all countries would be allowed to export the vaccine. Also, he has issued a joint public statement to dispel any misunderstanding regarding India Biotech. The Serum Institute of India and Bharat Biotech issued a joint statement on Tuesday. In their statement, the vaccine makers both said that their coronary vaccine is available for all countries.
“We are fully aware of the importance of vaccines for people and countries, and we have made a joint commitment to deliver our COVID-19 vaccines worldwide,” the Serum Institute of India and India Biotech said in a joint statement. Repeat. “
Hyderabad-based Bharat Biotech tweeted, “Serim Institute of India and Bharat Biotech have jointly pledged to supply 19 Covid vaccines to the country and the world at ease.”
India’s drug regulator on Sunday approved the limited emergency use of the Oxford Covid-19 vaccine Covishield, produced by India’s Serum Institute and India Biotech’s home-grown vaccine Kovacin, which has led to a wider vaccination campaign.
Vaccines are needed to get public health and economic activities back on track initially. Now that two Covid-19 vaccines have been approved for emergency use in India, it is time to focus on production, supply and distribution.
In a joint statement, he said, “Both of our agencies are fully engaged in this activity and consider it their duty to the country and the world to ensure the rollout of vaccines on a larger scale. We are working to implement the Covid-19 vaccine as planned.”